SINGER JAMES R 13D and 13G filings for Verve Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-16 11:45 am Sale |
2023-12-31 | 13G | Verve Therapeutics, Inc. VERV |
SINGER JAMES R | 3,000,000 3.700% |
-2,000,000 (-40.00%) |
Filing |
| 2023-02-14 10:40 am Purchase |
2022-12-31 | 13G | Verve Therapeutics, Inc. VERV |
SINGER JAMES R | 5,000,000 8.100% |
2,535,000 (+102.84%) |
Filing |
| 2022-01-24 08:22 am Purchase |
2022-01-13 | 13G | Verve Therapeutics, Inc. VERV |
SINGER JAMES R | 2,465,000 5.100% |
2,465,000 (New Position) |
Filing |